All technical FAQ related to dematerialisation initiative.
All Technical FAQ related to Validity Period.
Usefull Links on the validity period
All FAQ related to SAM V2
Usefull links on SAM V2
All FAQ related to Regulation
Our current application uses as a data source the APB delphicare database. Are we going to have the SAM version information in this database, which would allow us not to have to rewrite our current application?
Extended RID format: on page 3 you speak of the “month of creation of the prescription”, on page 22 (4.7) it says that it is the “day of creation”. Please clarify
The detailed description that contains the date (day) of creation is explicitly written out in 4.7; for efficiency of Recip-e it is important that the creation month can be derived from the “extension”, so that you can immediately look into the correct monthly table.
On page 2 you talk about 5 extra fields in the recip-e header, on page 3/4 (header modifications) the MGUID field is also displayed. Please clarify
Digital RID is also expected to be much more extended, which allows also much less printing. Printing RID should not be encouraged. Digital RID (if there is a possibility to digitalize this) can be encouraged.
There is a big dependency of the patientplatforms that will be setting the visiflags and ensure some guarantee/ choices on privacy of the prescriptions. As long as these are not created (we do not know the exact dates), we need to lock the digital access to Recip-e by the pharmacist.
Be Careful! Until the visiflags are implemented all prescriptions without flags will be set on “locked” to open based on INSZ functions (ListRelations, ListOpenPrescriptions, ListRidsHistory). As such we are sure that the privacy choice of the patient is met.
Afterwards, when the flags are developed/ implemented, they can have the status as provided in the specifications.
Pharmacy only needs RID and patient only proof -> do we only print the barcode or the entire prescription in the proposed layout?
The Mandate for third parties, Is this the specific pharmacist who can consult the prescription or is this something else – mandate to someone else to consult / collect the prescription
Deadlines are clear, but not from when development is possible or from when something can go live. Completion V4 in September = time to start? Or possible in advance (outside of due date)
Error handling? Per medication successful or not successful -> how to detect when there is a mistake?
VISI flag: For prescribers only LOCKED / OPEN can be provided – status PHARMACY only adaptable in tool patient – is this correct?
The General Principles state that the therapeutic relationship must be made between pharmacist / patient to see the prescriptions. How do you see that in the hospital setting? Is it possible via the circle of trust?
Is there clarity about what an “item” actually entails? Is it a box of a medicine or can there be multiple packages per RID?
Listrelations is necessary to check if a third person is really mandated. A pharmacist can only legally open the list of prescriptions if this third person is proven to have a mandate (which is normally indicated by the patient through the patient platform).